IOL Chemicals & Pharmaceuticals Ltd Financials
Company Logo

IOL Chemicals & Pharmaceuticals Ltd Financial Statement

IOL Chemicals & Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue532.30
Operating Expense464.84
Net Profit31.62
Net Profit Margin5.94
Earning Per Share5.38
EBIDTA61.24
Effective Tax Rate10.47

IOL Chemicals & Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual2,132.79
Operating Expenses Annual1,901.27
Operating Profit Annual261.59
Interest Annual16.10
Depreciation62.85
Net Profit Annual135.42
Tax Annual47.22

IOL Chemicals & Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.96
Cash Flow from Operations290.76
Cash Flow from Investing-191.69
Cash Flow from Financing-92.50
Cash Flow at the End7.53

IOL Chemicals & Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)12.27
PBIT Margin (%)9.32
PBT Margin (%)8.74
Net PROFIT Margin (%)6.35
Return On Networth / Equity (%)8.69
Return On Networth /Employed (%)12.27
Return On Assets (%)8.38
Total Debt / Equity (X)0.04
Asset Turnover Ratio (%)1.32

IOL Chemicals & Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual933.73
Total Current Assets Annual1,119.48
Non Current Assets Annual1,124.49
Total Shareholders Funds Annual1,611.33
Total Assets Annual2,243.97

IOL Chemicals & Pharmaceuticals Ltd Earning Calls

EPS (INR)

Expected

1.07

Reported

1.07

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.00%

Jun 2024

EPS beaten by 0.00%

FAQS on IOL Chemicals & Pharmaceuticals Ltd Financials

As of May 19, 2025, IOL Chemicals & Pharmaceuticals Ltd has a market capitalization of 1,796.39 Cr. Value Research classifies it as a Small-Cap company.

Yes, IOL Chemicals & Pharmaceuticals Ltd is with a debt-to-equity ratio of 0.07.

In FY 2024 , IOL Chemicals & Pharmaceuticals Ltd recorded a total revenue of approximately 2,079.21 Cr marking a significant milestone in the company's financial performance.

IOL Chemicals & Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and -0.0% annually, respectively..

IOL Chemicals & Pharmaceuticals Ltd's current PE ratio is 17.79.

IOL Chemicals & Pharmaceuticals Ltd's ROCE averaged 11.2% from the FY ending March 2023 to 2025, with a median of 12.1%. It peaked at 13.0% in March 2023, reflecting strong capital efficiency over the period..

IOL Chemicals & Pharmaceuticals Ltd's latest EBIT is Rs. 152.65 Cr, surpassing the average EBIT of Rs. 185.78 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions